Manila Times Business
ThruFlo Endovascular Secures Seed Funding to Advance First Purpose-Built Flow Diverter for Bifurcation Aneurysms
IRVINE, Calif., June 10, 2026 (GLOBE NEWSWIRE) -- ThruFlo Endovascular, Inc., a neuro-endovascular medical device company, today announced the completion of seed funding led by Atlas MedInnovation (Irvine, CA) to accelerate development of its novel bifurcated flow diverter platform. Proceeds will be used to establish formal R&D operations, complete device design, initiate additional pre-clinical studies, and submit an Investigational Device Exemption (IDE) application to the FDA. Cerebral aneury
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
Debut Novel by Susan Price Brings 1970s Newport to Life in Summer Read
Just now
West Red Lake Gold Announces Results of Annual General Meeting
Just now
Fennec Announces Results of Annual Meeting
Just now
Credit Acceptance Announces Appointment of Joe Billante as Chief Financial Officer; Jay Martin to Retire After More Than Two Decades of Service
Just now